Schizophrenia
27 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Aripiprazole for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| Aripiprazole + IEM (Ingestible Event Marker) for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bupropion + Escitalopram + Venlafaxine + SERTRALINE for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Clozapine for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Deep Brain Stimulation for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Diet-as-Usual (DAU) + LCHF Ketogenic Diet for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ecig 24 mg nicotine for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Emraclidine for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for schizophrenia | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Evenamide 15 mg bid for schizophrenia, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| GXV-813 for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| HS-10380 for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Iclepertin for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| KarX-EC + KarXT for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| KarXT for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic Diet for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ketogenic diet intervention for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ML-007C-MA for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Navigate for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NBI-1117570 for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Nmdae for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| NMDAE plus AIFA for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Olz/sam for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for schizophrenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Risperidone for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Ulotaront for schizophrenia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Xingqi Daozhi Decoction for schizophrenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |